Cambridge Equities, Lp - Net Worth and Insider Trading

Cambridge Equities, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cambridge Equities, Lp owns 4 companies in total, including NantKwest Inc (NK) , NantHealth Inc (NHIQ) , and Sorrento Therapeutics Inc (SRNE) among others .

Click here to see the complete history of Cambridge Equities, Lp’s form 4 insider trades.

Insider Ownership Summary of Cambridge Equities, Lp

Ticker	Comapny	Transaction Date	Type of Owner
NK	NantKwest Inc	2020-06-29	10 percent owner
NHIQ	NantHealth Inc	2016-12-21	10 percent owner
SRNE	Sorrento Therapeutics Inc	2014-12-22	10 percent owner
		2023-09-11	10 percent owner

Cambridge Equities, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cambridge Equities, Lp Ownership Network

Ownership Network List of Cambridge Equities, Lp

No Data

Ownership Network Relation of Cambridge Equities, Lp

Cambridge Equities, Lp Owned Company Details

What does NantKwest Inc do?

Who are the key executives at NantKwest Inc?

Cambridge Equities, Lp is the 10 percent owner of NantKwest Inc. Other key executives at NantKwest Inc include director & See remarks Barry J. Simon , Chief Financial Officer Sonja Nelson , and director & 10 percent owner & Chairman and CEO Patrick Soon-shiong .

NantKwest Inc (NK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantKwest Inc (NK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantKwest Inc (NK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantKwest Inc (NK)'s detailed insider trading history can be found in Insider Trading Tracker table.

NantKwest Inc Insider Transactions

No Available Data

What does NantHealth Inc do?

Who are the key executives at NantHealth Inc?

Cambridge Equities, Lp is the 10 percent owner of NantHealth Inc. Other key executives at NantHealth Inc include director & 10 percent owner & Chief Executive Officer Rao Haris Naseem , 10 percent owner Summus Holdings Llc , and Chief Operating Officer Ronald Allen Louks .

NantHealth Inc (NHIQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantHealth Inc (NHIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantHealth Inc (NHIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantHealth Inc (NHIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

NantHealth Inc Insider Transactions

No Available Data

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Cambridge Equities, Lp is the 10 percent owner of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Therapeutics Inc Insider Transactions

No Available Data

What does ImmunityBio Inc do?

Who are the key executives at ImmunityBio Inc?

Cambridge Equities, Lp is the 10 percent owner of ImmunityBio Inc. Other key executives at ImmunityBio Inc include director & 10 percent owner & See remarks Patrick Soon-shiong , 10 percent owner California Capital Equity, Llc , and 10 percent owner Nant Capital, Llc .

ImmunityBio Inc (IBRX) Insider Trades Summary

Over the past 18 months, Cambridge Equities, Lp made no insider transaction in ImmunityBio Inc (IBRX). Other recent insider transactions involving ImmunityBio Inc (IBRX) include a net purchase of 71,915 shares made by Michael D Blaszyk , a net purchase of 25,000 shares made by John Owen Brennan , and a net purchase of 7,000 shares made by Wesley Clark .

In summary, during the past 3 months, insiders sold 0 shares of ImmunityBio Inc (IBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmunityBio Inc (IBRX) were sold and 103,915 shares were bought by its insiders, resulting in a net purchase of 103,915 shares.

ImmunityBio Inc (IBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImmunityBio Inc Insider Transactions

No Available Data

Cambridge Equities, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Cambridge Equities, Lp. You might contact Cambridge Equities, Lp via mailing address: 9922 Jefferson Boulevard, Culver City Ca 90232.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.